Chargement en cours...
Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity
Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | Artigo |
Langue: | Inglês |
Publié: |
Endocrinology Research Centre
2018-12-01
|
Collection: | Ожирение и метаболизм |
Sujets: | |
Accès en ligne: | https://www.omet-endojournals.ru/jour/article/view/9584 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|